Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury Lawsuit comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits should be centralized before one judge. September 16, 2024 Russell Maas Add Your Comments A California woman has filed a product liability lawsuit against the manufacturers of the Angiodynamics LifePort, alleging that one of the implantable port catheters failed and fractured inside her body, requiring surgical removal. The complaint (PDF) was brought by Laura Schultz in the U.S. District Court Eastern District of California on September 9, pursuing damages from the device manufacturers, Angiodynamics, Inc. and Navilyst Medical, Inc. The Angiodynamics LifePort is an implantable port catheter that was approved by the U.S. Food and Drug Administration (FDA) in 2005, to allow long-term access to the vascular system to deliver medications, nutrients and treatments such as chemotherapy directly into the bloodstream. While the LifePort has been marketed as a safe and effective treatment for individuals undergoing chemotherapy or those requiring long term venous access, the devices have been linked to a growing number of AngioDynamics port catheter lawsuits over port catheter fracture, migration and infection injuries, which lawsuits now claim are caused by the use of defective materials that can weaken the structural integrity of the devices. ANGIODYNAMICS PORT CATHETER LAWSUIT Did you receive aN ANGIODYNAMICS pORT CATHETER? Serious and life-threatening injuries have been linked to problems with AngioDynamics port catheters. Lawsuits are being filed by those who suffered injuries from the implantable port catheter fracturing, migrating or causing infections. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ANGIODYNAMICS PORT CATHETER LAWSUIT Did you receive aN ANGIODYNAMICS pORT CATHETER? Serious and life-threatening injuries have been linked to problems with AngioDynamics port catheters. Lawsuits are being filed by those who suffered injuries from the implantable port catheter fracturing, migrating or causing infections. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to this Angiodynamics lawsuit, Schultz states she received an implantable LifePort catheter system in February 2009, before receiving chemotherapy treatment for breast cancer. However, Schultz states that she began to experience irregular heart rate side effects in November 2009, and was later admitted to Stanislaus Surgical Hospital in Modesto, California, where a review of imaging scans determined the LifePort had thrombosed and fractured, allowing pieces of the LifePort to migrate into her right atrium, which is the right upper chamber of the heart that receives deoxygenated blood from the body and pumps it to the lungs for oxygenation. Following the discovery, Shultz underwent surgical removal of the LifePort catheter system to remove the fractured and thrombosed components of the LifePort reservoir and the parts of the dislodged catheter. Similar to other Angiodynamics port catheter lawsuits filed to date, Shultz argues that the LifePort’s design, specifically the high concentration of barium sulfate in the catheter material, contributed to the thrombosis and fracturing of the device. The lawsuit claims the degradation of the barium sulfate used to design the LifePort creates a rough surface within the catheter, promoting the accumulation of fibrinous material from the bloodstream, ultimately leading to clot formation and the fracturing and migrating of the device. Schultz claims that Angiodynamics knew about the high risk of these port catheter thrombosis and fracturing problems through adverse event reports submitted to the FDA, but failed to warn patients, the medical industry or federal regulators. “Defendants had sole access to material facts concerning the defective nature of the LifePort product and its propensity to cause serious and dangerous side effects, such as catheter fracture, fracture and migration, and the catheter-related thrombosis,” Schultz’s lawsuit states. “Defendants intentionally underreported the number and nature of adverse events associated with fracture and migration of the devices and the catheter-related thrombosis to the Plaintiff’s health care providers, as well as the FDA.” She presents claims of negligence, defective design and manufacturing, failure to warn, breach of warranty and fraudulent concealment, seeking both punitive and compensatory damages. Potential Consolidation of Angiodynamics Port Catheter Lawsuits Schultz’s LifePort lawsuit against Angiodynamics joins more than 20 separate lawsuits filed against the medical device manufacturer, each raising similar claims that various implantable port catheters made by Angiodynamics such as the Vortex, Xcela and others, contain design defects that make them prone to fracture, migration and infection problems. Given the growing number of claims being filed in multiple federal courts nationwide, several plaintiffs with pending claims filed a motion to transfer Angiodynamics port catheter lawsuits with the U.S. Judicial Panel on Multidistrict Litigation (JPML) in July 2024. The plaintiff’s requested that all lawsuits brought over Angiodynamics port catheter defects throughout the federal court system be consolidated and centralized for pretrial proceedings in the U.S. District Court for the Western District of Missouri. In response to the motion, the JPML is now scheduled to hear oral arguments from both plaintiffs and defendants on September 26, 2024, in which the parties will present evidence to support or challenge consolidating and centralizing the cases before one judge for pretrial proceedings as part of an Angiodynamics Port Catheter multidistrict litigation. The allegations are similar to those made in a growing number of Bard PowerPort lawsuits being pursued against C.R. Bard, each indicating that the PowerPort is prone to fracturing, migrating and causing infections due to the breakdown of barium sulfate used during the manufacturing process. Given nearly identical allegations raised in the complaints brought against Bard throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation decided to centralize all Bard PowerPort lawsuits in August 2023, transferring the claims to U.S. District Judge David G. Campbell, in the District of Arizona, for coordinated discovery and pretrial proceedings as part of a federal MDL, or multidistrict litigation. Similar to the Bard PowerPort lawsuits, if an MDL is established, complaints filed against Angiodynamics in U.S. District Courts throughout the country will be transferred to one judge for discovery, pretrial proceedings and potentially a series of early bellwether trials. However, if the parties fail to reach an Angiodynamics port catheter settlement agreement or another resolution during the MDL proceedings, each lawsuit may be transferred back to their originating districts for individual trial dates in the future. Tags: Angiodynamics, Catheter Fracture, Catheter Migration, Chemo Port, Implantable Port Catheter, LifePort Catheter Image Credit: Pavel Kapysh More AngioDynamics Port Catheter Lawsuit Stories SmartPort Lawsuit Filed After Port Catheter Fracture Requires Surgical Removal March 28, 2025 Bard PowerPort Bellwether Trial Selections To Be Made in Late April 2025 March 26, 2025 AngioDynamics Lawsuit Claims Xcela Port Catheter Caused Acute Embolism March 19, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 5 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 5 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. MORE ABOUT: HAIR DYE LAWSUITHair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (03/20/2025)Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)